Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weishi Yuan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Computer Methods and Programs in Biomedicine|July 22, 2004
Regression models for unbalanced longitudinal ordinal data: computer software and a simulation studyKai Fun Yu, Weishi Yuan
Science (New York, N.Y.)|August 17, 2002
Allelic variation in human gene expressionHai Yan, Weishi Yuan, Victor E Velculescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung CancerDickran Kazandjian, Gideon M Blumenthal, Weishi Yuan, et al.
Pediatric Blood & Cancer|November 27, 2020
A review of the experience with pediatric written requests issued for oncology drug productsAlemayehu Y Akalu, Xi Meng, Gregory H Reaman, et al.
Physical Review Letters|May 2, 2022
Freezing of the Lattice in the Kagome Lattice Heisenberg Antiferromagnet Zn-Barlowite ZnCu_{3}(OD)_{6}FBrJiaming Wang, Weishi Yuan, Philip M Singer, et al.
The Oncologist|April 7, 2018
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release SyndromeRobert Q Le, Liang Li, Weishi Yuan, et al.
Retrovirology|September 24, 2008
beta-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBLMingjie Zhang, Qingsheng Huang, Yong Huang, et al.
The Oncologist|May 24, 2017
FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing ChemotherapyErin Larkins, Gideon M Blumenthal, Weishi Yuan, et al.
Oncology|June 10, 2010
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantationMichael Brave, Ann Farrell, Sue Ching Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2018
FDA's Approval of the First Biosimilar to BevacizumabSandra J Casak, Steven J Lemery, Jee Chung, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Computer Methods and Programs in Biomedicine|July 22, 2004
Regression models for unbalanced longitudinal ordinal data: computer software and a simulation studyKai Fun Yu, Weishi Yuan
Science (New York, N.Y.)|August 17, 2002
Allelic variation in human gene expressionHai Yan, Weishi Yuan, Victor E Velculescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung CancerDickran Kazandjian, Gideon M Blumenthal, Weishi Yuan, et al.
Pediatric Blood & Cancer|November 27, 2020
A review of the experience with pediatric written requests issued for oncology drug productsAlemayehu Y Akalu, Xi Meng, Gregory H Reaman, et al.
Physical Review Letters|May 2, 2022
Freezing of the Lattice in the Kagome Lattice Heisenberg Antiferromagnet Zn-Barlowite ZnCu_{3}(OD)_{6}FBrJiaming Wang, Weishi Yuan, Philip M Singer, et al.
The Oncologist|April 7, 2018
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release SyndromeRobert Q Le, Liang Li, Weishi Yuan, et al.
Retrovirology|September 24, 2008
beta-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBLMingjie Zhang, Qingsheng Huang, Yong Huang, et al.
The Oncologist|May 24, 2017
FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing ChemotherapyErin Larkins, Gideon M Blumenthal, Weishi Yuan, et al.
Oncology|June 10, 2010
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantationMichael Brave, Ann Farrell, Sue Ching Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2018
FDA's Approval of the First Biosimilar to BevacizumabSandra J Casak, Steven J Lemery, Jee Chung, et al.
Pageof 2